BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 24361962)

  • 1. Arsenic programmes cellular genomic-immunity through miR-2909 RNomics.
    Kaul D; Sharma S; Sharma M; Arora M; Arora M
    Gene; 2014 Feb; 536(2):326-31. PubMed ID: 24361962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MALT1 induced immune response is governed by miR-2909 RNomics.
    Kaul D; Arora M; Garg A; Sharma S
    Mol Immunol; 2015 Mar; 64(1):210-7. PubMed ID: 25500259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of cellular Cyclin D1 gene by arsenic is mediated through miR-2909.
    Sharma M; Sharma S; Arora M; Kaul D
    Gene; 2013 Jun; 522(1):60-4. PubMed ID: 23562784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High glucose-induced human cellular immune response is governed by miR-2909 RNomics.
    Kaul D; Sharma S
    Blood Cells Mol Dis; 2015 Apr; 54(4):342-7. PubMed ID: 25616369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of microRNA miR-526a by enterovirus inhibits RIG-I-dependent innate immune response.
    Xu C; He X; Zheng Z; Zhang Z; Wei C; Guan K; Hou L; Zhang B; Zhu L; Cao Y; Zhang Y; Cao Y; Ma S; Wang P; Zhang P; Xu Q; Ling Y; Yang X; Zhong H
    J Virol; 2014 Oct; 88(19):11356-68. PubMed ID: 25056901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response.
    Friedman CS; O'Donnell MA; Legarda-Addison D; Ng A; Cárdenas WB; Yount JS; Moran TM; Basler CF; Komuro A; Horvath CM; Xavier R; Ting AT
    EMBO Rep; 2008 Sep; 9(9):930-6. PubMed ID: 18636086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral B cells may serve as a reservoir for persistent hepatitis C virus infection.
    Ito M; Masumi A; Mochida K; Kukihara H; Moriishi K; Matsuura Y; Yamaguchi K; Mizuochi T
    J Innate Immun; 2010; 2(6):607-17. PubMed ID: 20714117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha interferon potently enhances the anti-human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells.
    Chen K; Huang J; Zhang C; Huang S; Nunnari G; Wang FX; Tong X; Gao L; Nikisher K; Zhang H
    J Virol; 2006 Aug; 80(15):7645-57. PubMed ID: 16840343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-viral protein APOBEC3G is induced by interferon-alpha stimulation in human hepatocytes.
    Tanaka Y; Marusawa H; Seno H; Matsumoto Y; Ueda Y; Kodama Y; Endo Y; Yamauchi J; Matsumoto T; Takaori-Kondo A; Ikai I; Chiba T
    Biochem Biophys Res Commun; 2006 Mar; 341(2):314-9. PubMed ID: 16426578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhibitory effect of apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G (APOBEC3G) and its family members on the activity of cellular microRNAs.
    Zhang H
    Prog Mol Subcell Biol; 2010; 50():71-83. PubMed ID: 19841882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOBEC3G governs to ensure cellular oncogenic transformation.
    Garg A; Kaul D; Chauhan N
    Blood Cells Mol Dis; 2015 Oct; 55(3):248-54. PubMed ID: 26227855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flavivirus induces interferon-beta gene expression through a pathway involving RIG-I-dependent IRF-3 and PI3K-dependent NF-kappaB activation.
    Chang TH; Liao CL; Lin YL
    Microbes Infect; 2006 Jan; 8(1):157-71. PubMed ID: 16182584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOBEC3G has the ability to programme T cell plasticity.
    Garg A; Kaul D
    Blood Cells Mol Dis; 2016 Jul; 59():108-12. PubMed ID: 27282578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.
    Mangeat B; Turelli P; Caron G; Friedli M; Perrin L; Trono D
    Nature; 2003 Jul; 424(6944):99-103. PubMed ID: 12808466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA control of interferons and interferon induced anti-viral activity.
    Sedger LM
    Mol Immunol; 2013 Dec; 56(4):781-93. PubMed ID: 23962477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonstructural protein 1α subunit-based inhibition of NF-κB activation and suppression of interferon-β production by porcine reproductive and respiratory syndrome virus.
    Song C; Krell P; Yoo D
    Virology; 2010 Nov; 407(2):268-80. PubMed ID: 20850164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-98 Promotes Apoptosis of Glioma Cells via Suppressing IKBKE/NF-κB Pathway.
    Wang L; Guo S; Zhang H
    Technol Cancer Res Treat; 2017 Dec; 16(6):1226-1234. PubMed ID: 29333957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
    Cui J; Chen Y; Wang HY; Wang RF
    Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High level expression of the anti-retroviral protein APOBEC3G is induced by influenza A virus but does not confer antiviral activity.
    Pauli EK; Schmolke M; Hofmann H; Ehrhardt C; Flory E; Münk C; Ludwig S
    Retrovirology; 2009 Apr; 6():38. PubMed ID: 19371434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.